Guardion Health Sciences, Inc.
GHSI · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $13 | $12 | $7 | $9 |
| - Cash | $15 | $6 | $6 | $8 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2 | $6 | $0 | $2 |
| Revenue | $0 | $3 | $3 | $3 |
| % Growth | -97.6% | 2.2% | -12% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 49.8% | 39.3% | 45.8% | 43.8% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,869.1% | -46.4% | -23.4% | -23% |
| Net Income | $10 | -$5 | $0 | $0 |
| % Margin | 14,158.8% | -158.2% | 14.5% | 11.2% |
| EPS Diluted | 8.04 | -3.71 | 0.33 | 0.29 |
| % Growth | 316.7% | -1,224.2% | 13.8% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |